Journal of Infection and Public Health
Volume 2, Issue 4 , Pages 157-166 , 2009

Swine flu

Received 9 June 2009 ,Revised 20 August 2009 ,Accepted 27 August 2009.

References 

  1. Centers for Disease Control and Prevention . Swine Influenza A (H1N1) infection in two children-Southern California, March–April 2009. MMWR. 2009;58:400–402
  2. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. Swine influenza viruses: a North American perspective. Adv Virus Res. 2008;72:127–154
  3. World Health Organization. Epidemic and Pandemic Alert and Response (EPR): Influenza A (H1N1)—update 62. Available at: http://www.who.int/csr/don/2009_08_19/en/index.html; 2009 [accessed August 19, 2009].
  4. Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med. 2009;7:30
  5. Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States France and Australia: transmission and prospects for control. Epidemiol Infect. 2007;136:852–864
  6. Blachere FM, Lindsley WG, Pearce TA, Anderson TE, Fisher M, Rashida K, et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis. 2009;48:438–440
  7. JAVMA News . J Am Vet Med Assoc. 2009;234:576–596
  8. Fraser C, Donnelly C, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324:1557–1561
  9. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775–785
  10. Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis. 2009;199:1435–1441
  11. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol. 2004;59:1–15
  12. Webster RG. Immunity to influenza in the elderly. Vaccine. 2000;18:1686–1689
  13. Centers for Disease Control and Prevention. Interim guidance for clinicians on identifying and caring for patients with Swine-Origin Influenza A (H1N1) virus infection, http://www.cdc.gov/swineflu/identifyingpatients.htm; 2009 [accessed August 5, 2009].
  14. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis. 2005;11:201–209
  15. Cox NJ, Subbarao K. Influenza. Lancet. 1999;354:1277–1282
  16. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel Swine-Origin Influenza A (H1N1) virus in humans. N Engl J Med. 2009;361:1–10
  17. Hospitalized patients with novel influenza A (H1N1) virus infection—California, April–May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536
  18. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E. Pneumonia and respiratory failure from Swine-Origin Influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–689
  19. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–458
  20. Neurologic complications associated with novel influenza A (H1N1) virus infection in children—Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:773
  21. Stamboulian D, Bonvehí PE, Nacinovich FM, Cox N. Influenza. Infect Dis Clin North Am. 2000;14:141–166
  22. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med. 2009;360:2616–2625
  23. Center for Infectious Disease Research and Policy. CDC: H1N1 spreads about as readily as seasonal flu, May 20, 2009.
  24. World Health Organization . Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec. 2009;84:185
  25. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel Swine-Origin Influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605
  26. Update: novel influenza A (H1N1) virus infections—worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:453
  27. Center for Infectious Disease Research and Policy. CDC: Novel H1N1 Flu: Facts and Figures, http://www.cdc.gov/h1n1flu/surveillanceqa.htm; 2009 [accessed August 12, 2009].
  28. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186
  29. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, Fraser C, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009;339:b2840
  30. World Health Organization. Human infection with new influenza A (H1N1) virus: Interim WHO guidance for the surveillance of human infection with A(H1N1) virus, http://www.who.int/csr/disease/swineflu/WHO_case_definition_swine_flu_2009_04_29.pdf; 2009 [accessed August 15, 2009].
  31. Poon LL, Chan KH, Smith GJ, Leung CS, Guan Y, Yuen KY, et al. Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays. Clin Chem. 2009;55:1555–1558
  32. Hurt AC, Baas C, Deng YM, Roberts S, Kelso A, Barr IG. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respi Viruses. 2009;3:171–176
  33. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol. 2009;45:191
  34. Chan KH, Lai ST, Poon LL, Guan Y, Yuen KY, Peiris JS. Analytical sensitivity of rapid influenza antigen detection tests for Swine-Origin Influenza virus (H1N1). J Clin Virol. 2009;45:205–207
  35. Centers for Disease Control and Prevention . Update: drug susceptibility of Swine Origin Influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:433–435
  36. Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ. 2009;339:b3172
  37. Fuyuno I. Tamiflu side effects come under scrutiny. Nature. 2007;446:358–359
  38. Cass LM, Efthymiopoulos C, Bye A. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet. 1999;36(suppl. 1):1–11
  39. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ. 2009;181:55–58
  40. Rasmussen SA, Jamieson DJ, Macfarlane K, Cragan JD, Williams J, Henderson Z. Pandemic influenza and pregnant women: Summary of a meeting of experts. Am J Public Health. 2009;(June):[Epub ahead of print]
  41. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16:216
  42. Jiménez-Caballero PE, Montes-Gonzalo MC, Velázquez-Pérez JM. Reye's syndrome: description of a case focused on the patient's epileptic seizures. Rev Neurol. 2008;47:571–574
  43. Centers for Disease Control and Prevention. Interim guidance on antiviral recommendations for patients with novel Influenza A (H1N1) virus infection and their close contacts. Available at:http://www.cdc.gov/h1n1flu/recommendations.htm; 2009 [accessed May 23, 2009].
  44. World Health Organization. Viruses resistant to oseltamivir (Tamiflu) identified, 8 July 2009, http://www.who.int/csr/disease/swineflu/newsbriefs/h1n1_antiviral_resistance_20090708/en/index.html; 2009 [accessed July 8, 2009].
  45. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, et al. Oseltamivir-resistant influenza virus A (H1N1), Europe 2007–08 season. Emerg Infect Dis. 2009;15:552–560
  46. Soundararajan V, Tharakaraman K, Raman R, Raguram S, Shriver Z, Sasisekharan V, et al. Extrapolating from sequence—the 2009 H1N1 ‘swine’ influenza virus. Nat Biotechnol. 2009;27:510–513
  47. Nguyen JT, Hoopes JD, Smee DF, Prichard MN, Driebe EM, Engelthaler DM, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother. 2009;(July):[Epub ahead of print]
  48. Hurt AC, Holien JK, Parker M, Kelso A, Barr IG. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol. 2009;(July):[Epub ahead of print]
  49. Carbonara S, Monno L, Longo B, Angarano G. Community-acquired pneumonia. Curr Opin Pulm Med. 2009;15:261–273
  50. World Health Organization. Clinical management of human infection with new influenza A (H1N1) virus: initial guidance, http://www.who.int/csr/resources/publications/swineflu/clinical_managementH1N1_21_May_2009.pdf; 2009 [accessed August 15, 2009].
  51. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086–5096
  52. World Health Organization. Strategic Advisory Group of Experts (SAGE) on Immunization, http://www.who.int/immunization/sage/en/index.html; 2009 [accessed July 8, 2009].
  53. Centers for Disease Control and Prevention (CDC). Recommendations for the amount of time persons with influenza-like illness should be away from others, http://www.cdc.gov/h1n1flu/guidance/exclusion.htm; 2009 [accessed August 15, 2009].
  54. MacIntyre CR, Cauchemez S, Dominic ED, Seale H, Cheung P, Browne G. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis. 2009;15:233–241
  55. Centers for Disease Control and Prevention (CDC). Interim guidance for airlines regarding flight crews arriving from domestic and international areas affected by swine influenza, http://www.cdc.gov/h1n1flu/guidance/air-crew-dom-intl.htm; 2009 [accessed August 15, 2009].
  56. Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM, et al. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA. 2007;298:644–654
  57. Loncarevic G, Payne L, Kon P, Petrovic V, Dimitrijevic D, Knezevic T, et al. Public health preparedness for two mass gathering events in the context of pandemic influenza (H1N1) 2009-Serbia July 2009. Euro Surveill. 2009;14(31):pii: 19296
  58. Berkman BE. Mitigating pandemic influenza: the ethics of implementing a school closure policy. J Public Health Manag Pract. 2008;14:372–378

PII: S1876-0341(09)00061-6

doi: 10.1016/j.jiph.2009.08.006

Journal of Infection and Public Health
Volume 2, Issue 4 , Pages 157-166 , 2009

Article Tools